What is vinculin needed for in platelets? by MITSIOS, J. V., PREVOST, N., KASIRER‐FRIEDE, A., GUTIERREZ, E., GROISMAN, A., ABRAMS, C. S., WANG, Y., LITVINOV, R. I., ZEMLJIC‐HARPF, A., ROSS, R. S., SHATTIL, S. J.

Get full text

Highly constrained cyclic (S,S) ‐CXaaC‐ peptides as inhibitors of fibrinogen binding to platelets by KOUKI, A., MITSIOS, J. V., SAKARELLOS‐DAITSIOTIS, M., SAKARELLOS, C., TSELEPIS, A. D., TSIKARIS, V., TSOUKATOS, D. C.

Get full text

PO10-279 PLATELET-DERIVED MICROPARTICLES INHIBIT THE OXIDATIVE MODIFICATION OF LDL POSSIBLY THROUGH THEIR PHOSPHATIDYLSERINE AND PLASMALOGEN CONTENT by Mitsios, J.V., Tsironis, L.D., Dimitriou, A.A., Tselepis, A.D.

Get full text

Tu-W26:4 Circulating microparticles of platelet origin are carriers of PAF-acetylhydrolase by Mitsios, J.V., Vini, M.P., Stengel, D., Ninio, E., Tselepis, A.D.

Get full text

4P-0972 Lipoprotein(a) inhibits PAF-induced activation of human platelets in a manner independent of the endogenous PAF-acetylhydrolase activity by Tselepis, A., Tsironis, L.D., Mitsios, J.V., Milionis, H.J., Elisaf, M.

Get full text

Platelets activated by thrombin secrete PAF-acetylhydrolase in the form of microparticles by Mitsios, J.V., Goudevenos, J., Elisaf, M., Tselepis, A.D.

Get full text

Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes by Mitsios, J.V, Papathanasiou, A.I, Rodis, F.I, Elisaf, M, Goudevenos, J.A, Tselepis, A.D

Get full text

3P-0843 Inhibition of platelet activation and fibrinogen binding to α11bβ3 using synthetic peptide-analogues derived from the β3 subunit: A comparative study by Tselepis, A.D., Rodi, F.I., Mitsios, J.V., Stathopoulos, P., Sakarellos-Daitsiotis, M., Sakarellos, C., Michalis, L.K., Goudevenos, J.A., Elisaf, M., Tsoukatos, D., Tsikaris, V., Sideris, D.A.

Get full text